NASDAQ$LUNG
Pulmonx Corporation · Q3 2023 earnings
Q3 2023 earnings · · Investor relations
Briefing
Pulmonx achieved record worldwide revenue driven by strength in the U.S.
Pulmonx reported record third-quarter results with worldwide revenue of $17.7 million, a 31% increase year-over-year. U.S. revenue grew by 41% to $11.8 million. The company is increasing its full-year revenue expectation to $67 million to $68 million.
- Achieved record worldwide revenue of $17.7 million, a 31% increase year-over-year.
- Delivered record U.S. revenue of $11.8 million, representing 41% year-over-year growth.
- Realized a gross margin of 74%.
- Added 15 new U.S. treatment centers for Zephyr Valves.
Headline financials
Revenue & EPS history
Pulmonx · Revenue · Quarterly
$17.7M
Forward guidance
Pulmonx is increasing its expectation for revenue in 2023 to now range from $67 million to $68 million and expects gross margin for the full year 2023 to be approximately 74%.
Tailwinds
- Revenue in 2023 to range from $67 million to $68 million.
- Represents approximately 25% to 27% growth over the Company's fiscal year 2022 revenue.
- Gross margin for the full year 2023 to be approximately 74%.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q3 2023
-3.4%
Avg return
Earnings day
-4.1%
Avg return
5 days after
-5.3%
Avg return
30 days after
42%
10 / 24 earnings
Positive
+32.2%
Q4 2024
Best reaction
-64.7%
Q3 2022
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -1.5% | -6.7% | +12.6% | |
| Q4 2025 | +0.6% | -6.1% | -28.2% | |
| Q3 2025 | -18.9% | -28.6% | +29.1% | |
| Q1 2025 | -21.9% | -28.8% | -29.6% | |
| Q4 2024 | +32.2% | +30.7% | +17.0% | |
| Q3 2024 | -7.7% | +5.2% | -4.7% | |
| Q2 2024 | -8.1% | -15.4% | +3.7% | |
| Q1 2024 | +23.3% | +21.9% | -4.7% | |
| Q4 2023 | -17.7% | -27.9% | -36.1% | |
| Q3 2023 | +6.9% | +20.7% | +34.2% | |
| Q2 2023 | -4.1% | -8.0% | -26.0% | |
| Q1 2023 | +1.1% | -0.2% | -1.5% | |
| Q4 2022 | +20.8% | +26.0% | +27.1% | |
| Q3 2022 | -64.7% | -61.1% | -52.3% | |
| Q2 2022 | +9.2% | +19.9% | +5.7% | |
| Q1 2022 | +0.6% | -23.6% | -23.9% | |
| Q4 2021 | -6.9% | -2.5% | -12.5% | |
| Q3 2021 | +7.1% | +12.6% | -23.7% | |
| Q2 2020 | -7.6% | -10.9% | -1.6% | |
| Q2 2021 | +0.1% | +6.0% | +3.3% | |
| Q1 2020 | -5.8% | -5.3% | +9.9% | |
| Q1 2021 | -8.7% | -9.6% | -10.3% | |
| Q4 2020 | -4.1% | -3.4% | -20.2% | |
| Q3 2020 | -4.9% | -3.4% | +5.6% | |
| Q4 2019 | — | — | — | |
| Q3 2019 | — | — | — | |
| Q2 2019 | — | — | — | |
| Q1 2019 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro